Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

5-MeO-MET

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
5-MeO-MET
Clinical data
Other names5-OMe-MET; 5-Methoxy-N-methyl-N-ethyltryptamine
Drug classSerotonin receptor modulator;Serotonin5-HT2A receptoragonist;Serotonergic psychedelic;Hallucinogen
Pharmacokinetic data
Onset of actionUnknown[1]
Duration of actionUnknown[1]
Identifiers
  • N-ethyl-2-(5-methoxy-1H-indol-3-yl)-N-methylethan-1-amine
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC14H20N2O
Molar mass232.327 g·mol−1
3D model (JSmol)
  • CCN(CCc1c[nH]c2c1cc(OC)cc2)C
  • InChI=1S/C14H20N2O/c1-4-16(2)8-7-11-10-15-14-6-5-12(17-3)9-13(11)14/h5-6,9-10,15H,4,7-8H2,1-3H3
  • Key:AVECDEWGCOLCPZ-UHFFFAOYSA-N

5-MeO-MET, also known as5-methoxy-N-methyl-N-ethyltryptamine, is aserotonin receptor modulator, putativeserotonergic psychedelic, and relatively raredesigner drug of thetryptamine family related to psychedelic drugs likemethylethyltryptamine (MET) and5-MeO-DMT.[2][3][4][5][6]

Use and effects

[edit]

5-MeO-MET was not included nor mentioned inAlexander Shulgin's bookTiHKAL (Tryptamines I Have Known and Loved).[1] Relatedly, its properties, such asdose andduration, and its effects were not described.[1]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Pharmacology

[edit]

Pharmacodynamics

[edit]

Early studies found 5-MeO-MET to be morepotent in animal behavioral tests than 5-MeO-DMT.[3][7] Subsequent studies confirmed that 5-MeO-MET interacts withserotonin receptors similarly to other psychedelic tryptamines.[8][9] A more modern study found that 5-MeO-MET is a potent serotonin5-HT1A receptorligand and serotonin5-HT2A receptoragonist and produces thehead-twitch response, a behavioral proxy of psychedelics, in rodents.[2][10] Its activities were of similar potency as 5-MeO-DMT.[2]

Chemistry

[edit]

Analogues

[edit]

Analogues of 5-MeO-MET includemethylethyltryptamine (MET),4-HO-MET (metocin),4-AcO-MET (metacetin),bretisilocin (5-fluoro-MET),7F-5-MeO-MET,5-MeO-DMT,5-MeO-DET,5-MeO-MPT,5-MeO-EPT,5-MeO-MALT, and5-MeO-MiPT, among others.

History

[edit]

5-MeO-MET was firstsynthesized and limitedly studied in the 1960s.[3][7][8] The drug was first identified on the illicit market in June 2012 in Sweden.[11] It was made illegal inNorway in 2013.[12]

See also

[edit]

References

[edit]
  1. ^abcdShulgin, Alexander;Shulgin, Ann (September 1997).TiHKAL: The Continuation.Berkeley, California:Transform Press.ISBN 0-9630096-9-9.OCLC 38503252.
  2. ^abcPuigseslloses P, Nadal-Gratacós N, Ketsela G, Weiss N, Berzosa X, Estrada-Tejedor R, Islam MN, Holy M, Niello M, Pubill D, Camarasa J, Escubedo E, Sitte HH, López-Arnau R (August 2024)."Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties".Mol Psychiatry.29 (8):2346–2358.doi:10.1038/s41380-024-02506-8.PMC 11412900.PMID 38486047.
  3. ^abcBrimblecombe RW, Pinder RM (1975). "Indolealkylamines and Related Compounds".Hallucinogenic Agents. Bristol: Wright-Scientechnica. pp. 98–144.ISBN 978-0-85608-011-1.OCLC 2176880.OL 4850660M.Compounds of interest which have not been tested in man include 5-methoxy-N-ethyl-N-methyltryptamine, which is more potent than the N,N-dimethyl analogue in behavioural tests in rodents (Gessner and others, 1968), [...]
  4. ^Schifano F, Orsolini L, Papanti D, Corkery J (2017). "NPS: Medical Consequences Associated with Their Intake".Neuropharmacology of New Psychoactive Substances (NPS). Current Topics in Behavioral Neurosciences. Vol. 32. pp. 351–380.doi:10.1007/7854_2016_15.ISBN 978-3-319-52442-9.PMID 27272067.
  5. ^Palma-Conesa ÁJ, Ventura M, Galindo L, Fonseca F, Grifell M, Quintana P, Fornís I, Gil C, Farré M, Torrens M (2017). "Something New about Something Old: A 10-Year Follow-Up on Classical and New Psychoactive Tryptamines and Results of Analysis".Journal of Psychoactive Drugs.49 (4):297–305.doi:10.1080/02791072.2017.1320732.PMID 28569652.S2CID 45394561.
  6. ^Malaca S, Lo Faro AF, Tamborra A, Pichini S, Busardò FP, Huestis MA (December 2020)."Toxicology and Analysis of Psychoactive Tryptamines".International Journal of Molecular Sciences.21 (23): 9279.doi:10.3390/ijms21239279.PMC 7730282.PMID 33291798.
  7. ^abGessner PK, Godse DD, Krull AH, McMullan JM (March 1968). "Structure-activity relationships among 5-methoxy-n:n-dimethyltryptamine, 4-hydroxy-n:n-dimethyltryptamine (psilocin) and other substituted tryptamines".Life Sciences.7 (5):267–77.doi:10.1016/0024-3205(68)90200-2.PMID 5641719.
  8. ^abGlennon RA, Gessner PK (April 1979). "Serotonin receptor binding affinities of tryptamine analogues".Journal of Medicinal Chemistry.22 (4):428–32.doi:10.1021/jm00190a014.PMID 430481.
  9. ^Klein MT, Dukat M, Glennon RA, Teitler M (June 2011)."Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships".J Pharmacol Exp Ther.337 (3):860–867.doi:10.1124/jpet.111.179606.PMC 3101003.PMID 21422162.
  10. ^Glatfelter GC, Clark AA, Cavalco NG, Landavazo A, Partilla JS, Naeem M (December 2024). "Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy-N,N-dimethyltryptamine Analogs in Mice".ACS Chem Neurosci.15 (24):4458–4477.doi:10.1021/acschemneuro.4c00513.PMID 39636099.
  11. ^"EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA"(PDF).New drugs in Europe, 2012.
  12. ^"Forskrift om endring i forskrift om narkotika" [Regulations amending the regulations on drugs].Lovdata (in Norwegian).

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
Cyclized tryptamines
Isotryptamines
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=5-MeO-MET&oldid=1323761659"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp